These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25204286)

  • 21. c-erbB-2/p185-directed therapy in human lung adenocarcinoma.
    Snider JM; Bushnell LJ; Chen LC; Lanza LA
    Ann Thorac Surg; 1996 Nov; 62(5):1454-9. PubMed ID: 8893583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
    Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
    J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
    Sundaresan G; Yazaki PJ; Shively JE; Finn RD; Larson SM; Raubitschek AA; Williams LE; Chatziioannou AF; Gambhir SS; Wu AM
    J Nucl Med; 2003 Dec; 44(12):1962-9. PubMed ID: 14660722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient induction of anti-tumor immunity by a TAT-CEA fusion protein vaccine with poly(I:C) in a murine colorectal tumor model.
    Park JS; Kim HS; Park HM; Kim CH; Kim TG
    Vaccine; 2011 Nov; 29(47):8642-8. PubMed ID: 21945963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Catch-and-Release" Anti-Carcinoembryonic Antigen Monoclonal Antibody Leads to Greater Plasma and Tumor Exposure in a Mouse Model of Colorectal Cancer.
    Engler FA; Polli JR; Li T; An B; Otteneder M; Qu J; Balthasar JP
    J Pharmacol Exp Ther; 2018 Jul; 366(1):205-219. PubMed ID: 29735609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiologically Based Modeling of the Pharmacokinetics of "Catch-and-Release" Anti-Carcinoembryonic Antigen Monoclonal Antibodies in Colorectal Cancer Xenograft Mouse Models.
    Polli JR; Engler FA; Balthasar JP
    J Pharm Sci; 2019 Jan; 108(1):674-691. PubMed ID: 30321546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transfer efficacy.
    Han T; Tang Y; Ugai H; Perry LE; Siegal GP; Contreras JL; Wu H
    Virol J; 2007 Oct; 4():103. PubMed ID: 17958897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.
    Cai W; Olafsen T; Zhang X; Cao Q; Gambhir SS; Williams LE; Wu AM; Chen X
    J Nucl Med; 2007 Feb; 48(2):304-10. PubMed ID: 17268029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic mAb-mAb interaction: anti-VEGF mAb decreases the distribution of anti-CEA mAb into colorectal tumor xenografts.
    Abuqayyas L; Balthasar JP
    AAPS J; 2012 Sep; 14(3):445-55. PubMed ID: 22528507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective anti-tumour immune responses by murine dendritic cells pulsed with recombinant Tat-carcinoembryonic antigen derived from Escherichia coli.
    Bae MY; Cho NH; Seong SY
    Clin Exp Immunol; 2009 Jul; 157(1):128-38. PubMed ID: 19659778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A gelonin-containing immunotoxin directed against human breast carcinoma.
    Rosenblum MG; Zuckerman JE; Marks JW; Rotbein J; Allen WR
    Mol Biother; 1992 Sep; 4(3):122-9. PubMed ID: 1445665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antileukemic efficacy of an immunotoxin composed of a monoclonal anti-Thy-1 antibody disulfide linked to the ribosome-inactivating protein gelonin.
    Scott CF; Goldmacher VS; Lambert JM; Chari RV; Bolender S; Gauthier MN; Blättler WA
    Cancer Immunol Immunother; 1987; 25(1):31-40. PubMed ID: 3496157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
    Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
    Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxin-targeted design for anticancer therapy. II: Preparation and biological comparison of different chemically linked gelonin-antibody conjugates.
    Delprino L; Giacomotti M; Dosio F; Brusa P; Ceruti M; Grosa G; Cattel L
    J Pharm Sci; 1993 Jul; 82(7):699-704. PubMed ID: 8360843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient Inhibition of Trastuzumab-Tumor Binding to Overcome the "Binding-Site Barrier" and Improve the Efficacy of a Trastuzumab-Gelonin Immunotoxin.
    Chen P; Bordeau BM; Zhang Y; Balthasar JP
    Mol Cancer Ther; 2022 Oct; 21(10):1573-1582. PubMed ID: 35930739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular re-localisation by photochemical internalisation enhances the cytotoxic effect of gelonin--quantitative studies in normal rat liver.
    Woodhams J; Lou PJ; Selbo PK; Mosse A; Oukrif D; MacRobert A; Novelli M; Peng Q; Berg K; Bown SG
    J Control Release; 2010 Mar; 142(3):347-53. PubMed ID: 19932724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTD-modified ATTEMPTS system for enhanced asparaginase therapy: a proof-of-concept investigation.
    Kwon YM; Li YT; Liang JF; Park YJ; Chang LC; Yang VC
    J Control Release; 2008 Sep; 130(3):252-8. PubMed ID: 18652856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties.
    Pirie CM; Hackel BJ; Rosenblum MG; Wittrup KD
    J Biol Chem; 2011 Feb; 286(6):4165-72. PubMed ID: 21138845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved Protein Toxin Delivery Based on ATTEMPTS Systems.
    Chen Y; Zhang M; Min KA; Wang H; Shin MC; Li F; Yang VC; Huang Y
    Curr Drug Targets; 2018 Feb; 19(4):380-392. PubMed ID: 28260497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunotoxins composed of monoclonal antibody to alpha-fetoprotein and gelonin as a potent hepatoma-targeted drug delivery system.
    Masuda K; Takahashi K; Nagata S; Hirano K; Takagishi Y
    J Drug Target; 1994; 2(4):323-31. PubMed ID: 7532086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.